Maximized nanodrug-loaded mesenchymal stem cells by a dual drug-loaded mode for the systemic treatment of metastatic lung cancer

References

• Amara I, Touati W, Beaune P, et al. (2014). Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors. Biochimie 105:4–11.
   PubMed Web of Science ®Google Scholar
• Auffinger B. (2013). Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma. Oncotarget 4:378–96.
   PubMed Web of Science ®Google Scholar
• Augusto P, Arianna B, Valentina C, et al. (2011). Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy. PLoS One 6:e28321.
   PubMed Web of Science ®Google Scholar
• Cheng H, Byrska-Bishop M, Zhang C, et al. (2012). Stem cell membrane engineering for cell rolling using peptide conjugation and tuning of cell-selectin interaction kinetics. Biomaterials 33:5004–12.
   PubMed Web of Science ®Google Scholar
• Fligh M. (2012). Drug delivery: encapsulation improves therapeutic stem cell action. Nat Rev Drug Discov 11:106.
   Web of Science ®Google Scholar
• Gao Z, Zhang L, Hu J, et al. (2013). Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug loaded nanoparticles. Nanomedicine 9:174–84.
   PubMed Web of Science ®Google Scholar
• Hashemi M, Kalalinia F. (2015). Application of encapsulation technology in stem cell therapy. Life Sci 143:139–46.
   PubMed Web of Science ®Google Scholar
• Hong X, Ruowen S, Masahiko K, et al. (2009). Intratracheal delivery of CX3CL1-expressing mesenchymal stem cells to multiple lung tumors. Molecular Med 15:321–7.
   PubMed Web of Science ®Google Scholar
• Huang X, Zhang F, Wang H, et al. (2013). Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. Biomaterials 34:1772–80.
   PubMed Web of Science ®Google Scholar
• Kim C, Tae G. (2015). The modulation of biodistribution of stem cells by anchoring lipid-conjugated heparin on the cell surface. J Control Release 217:128–37.
   PubMed Web of Science ®Google Scholar
• Lesch H, Kaikkonen M, Pikkarainen J, et al. (2010). Avidin-biotin technology in targeted therapy. Expert Opin Drug Deliv 7:551–64.
   PubMed Web of Science ®Google Scholar
• Li L, Guan Y, Liu H, et al. (2011). Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano 5:7462–70.
   PubMed Web of Science ®Google Scholar
• Li Z, Fan D, Xiong D. (2015). Mesenchymal stem cells as delivery vectors for anti-tumor therapy. Stem Cell Investig 2:6.
   PubMedGoogle Scholar
• Lorena S, Venkata R, Giuseppe B. (2015). iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes. Biomaterials 104:247–57.
   Web of Science ®Google Scholar
• Meleshina A, Cherkasova E, Shirmanova M, et al. (2015). Influence of mesenchymal stem cells on metastasis development in mice in vivo. Stem Cell Res Ther 6:15.
   PubMed Web of Science ®Google Scholar
• Nateghian N, Goodarzi N, Amini M, et al. (2016). Biotin/folate-decorated human serum albumin nanoparticles of docetaxel: comparison of chemically conjugated nanostructures and physically loaded nanoparticles for targeting of breast cancer. Chem Biol Drug Des 87:69–82.
   PubMed Web of Science ®Google Scholar
• Pacioni S, Alessandris Q, Giannetti S, et al. (2015). Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts. Stem Cell Res Ther 6:194.
   PubMed Web of Science ®Google Scholar
• Park S, Suryaprakash S, Lao Y, et al. (2015). Engineering mesenchymal stem cells for regenerative medicine and drug delivery. Methods 84:3–16.
   PubMed Web of Science ®Google Scholar
• Sadhukha T, O'Brien T, Prabha S. (2014). Nano-engineered mesenchymal stem cells as targeted therapeutic carriers. J Control Release 196:243–51.
   PubMed Web of Science ®Google Scholar
• Shi J, Wu P, Jiang Z, et al. (2014). Synthesis and tumor cell growth inhibitory activity of biotinylated annonaceous acetogenins. Eur J Med Chem 71:219–28.
   PubMed Web of Science ®Google Scholar
• Sohni A, Verfaillie C. (2013). Mesenchymal stem cells migration homing and tracking. Stem Cells Int 2013:1–8.
   Web of Science ®Google Scholar
• Stephan M, Moon J, Um S, et al. (2010). Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med 16:1035–41.
   PubMed Web of Science ®Google Scholar
• Stephan M, Irvine D. (2011). Enhancing cell therapies from the outside in: cell surface engineering using synthetic nanomaterials. Nano Today 6:309–25.
   PubMed Web of Science ®Google Scholar
• Stuckey D, Shah K. (2014). Stem cell-based therapies for cancer treatment: separating hope from hype. Nat Rev Cancer 14:683–91.
   PubMed Web of Science ®Google Scholar
• Uchibori R, Tsukahara T, Ohmine K, et al. (2014). Cancer gene therapy using mesenchymal stem cells. Int J Hematol 99:377–82.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang X, Liu Y, et al. (2014). Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates. Biomaterials 35:8735–47.
   PubMed Web of Science ®Google Scholar
• Wang Q, Cheng H, Peng H, et al. (2015). Non-genetic engineering of cells for drug delivery and cell-based therapy. Adv Drug Deliv Rev 91:125–40.
   PubMed Web of Science ®Google Scholar
• Yan C, Song X, Yu W, et al. (2016). Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects. Tumour Biol 37:8425–35.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yao S, Liu C, et al. (2015). Tumor tropic delivery of doxorubicin-polymer conjugates using mesenchymal stem cells for glioma therapy. Biomaterials 39:269–81.
   PubMed Web of Science ®Google Scholar
• Zhu S, Hong M, Tang G, et al. (2010). Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style. Biomaterials 31:1360–71.
   PubMed Web of Science ®Google Scholar